cytarabine has been researched along with Infections, Roseolovirus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jackson, GH; Nicolle, AL; Stark, GL; Taylor, CE; Wipat, W | 1 |
| Cañete, A; Carvajal, E; Castel, V; Fernández, JM; Verdeguer, A | 1 |
2 other study(ies) available for cytarabine and Infections, Roseolovirus
| Article | Year |
|---|---|
Human herpesvirus 6 encephalitis following flag chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Encephalitis, Viral; Fatal Outcome; Granulocyte Colony-Stimulating Factor; Herpesvirus 6, Human; Humans; Immunocompromised Host; Male; Middle Aged; Opportunistic Infections; Roseolovirus Infections; Vidarabine | 2003 |
Herpesvirus-6 encephalitis complicated by Wernicke-Korsakoff syndrome in a pediatric recipient of unrelated cord blood transplantation.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Child; Combined Modality Therapy; Cytarabine; Daunorubicin; Encephalitis, Viral; Etoposide; Fatal Outcome; Female; Fetal Blood; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Herpesvirus 6, Human; Humans; Immunocompromised Host; Korsakoff Syndrome; Leukemia, Myeloid, Acute; Recurrence; Roseolovirus Infections; Transplantation Conditioning; Transplantation, Homologous; Virus Activation | 2001 |